WHO ICTRP trial
Comparison of efficacy of Indomethacin vs Paracetamol along with standard care…
CTRI/2021/05/033544 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2021/05/033544 |
|---|---|
| Public title | Comparison of efficacy of Indomethacin vs Paracetamol along with standard care of treatment in mild and moderate Covid-19 patients |
| Scientific title | A Prospective, randomized, open-labelled, active comparator trial of Indomethacin versus Paracetamol among hospitalized patients with confirmed Covid-19. |
| Primary sponsor | IIT Madras |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: J99- Respiratory disorders in diseasesclassified elsewhere |
| Interventions | Intervention1: Indomethacin: Drug dose - Capsule (C) - 75 mg sustained release formulation once daily for 5 days for subjects with BMI less than 30; C. 75 mg twice daily for 5 days for subjects with BMI more than 30 will be administered… |
| Registration date | Nov 5, 2021 |
| Target size | 300 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: